SCHEMBL5724545

SCHEMBL5724545

COc1ccc2c(c1)NC(S(=O)(=O)Cc1ncc(C)c(OC)c1C)(S(=O)(=O)c1ccc(O)cc1)N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.47
ATP4A P20648 5/20 0.39
ATP4B P51164 5/20 0.39
KMT2A Q03164 4/20 0.39
WDR5 P61964 3/20 0.39
BRS3 P32247 2/20 0.39
PKM P14618 2/20 0.39
ATP1A1 P05023 2/20 0.39
ATP1B1 P05026 2/20 0.39
ATP1A3 P13637 2/20 0.39
ATP1B2 P14415 2/20 0.39
ATP1A2 P50993 2/20 0.39
ATP1B3 P54709 2/20 0.39
FXYD2 P54710 2/20 0.39
ATP1A4 Q13733 2/20 0.39
DDAH1 O94760 2/20 0.39
ENGASE Q8NFI3 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ABCB11 O95342 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320866 0.74 CYP2C9 (0.40) CYP2C9ATP4AATP4BKMT2AWDR5
SCHEMBL9704226 0.69 BRS3 (0.46) CYP2C9ATP4AATP4BKMT2AWDR5
SCHEMBL3799564 0.66 AGXT (0.57) CYP2C9ATP4AATP4BKMT2AWDR5
SCHEMBL5331906 0.64 CYP2C9 (0.45) CYP2C9ATP4AATP4BKMT2AWDR5
SCHEMBL5339698 0.64 CYP2C9 (0.43) CYP2C9ATP4AATP4BKMT2AWDR5
Omeprazole Sulfone SCHEMBL29415504 0.64 CYP2C9 (0.85) CYP2C9ATP4AATP4BKMT2AWDR5
Omeprazole Sulfone SCHEMBL2340649 0.64 CYP2C9 (0.85) CYP2C9ATP4AATP4BKMT2AWDR5
Omeprazole Sulfone SCHEMBL33721996 0.64 CYP2C9 (0.85) CYP2C9ATP4AATP4BKMT2AWDR5
Omeprazole Sulfone SCHEMBL4950986 0.64 CYP2C9 (1.00) CYP2C9ATP4AATP4BKMT2AWDR5
SCHEMBL25476488 0.63 BRS3 (0.53) CYP2C9ATP4AATP4BKMT2AWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644352-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS Allergan, Inc. (US) 2006-04-12 EP disclosed
WO-2005016917-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS ALLERGAN, INC. (US) 2005-02-24 WO disclosed